Skip to content

En español


Thank You, Community!

By on November 25th, 2015 Categories: Inside

Thanksgiving in the United States is a holiday we love, when we show our gratitude for the people who inspire us, help us, and make a difference in our lives.

This Thanksgiving, on behalf of’s team of Discussion Board moderators, I want to thank you — all of our incredible community members! Although this is not a community anybody ever wants to join, and …

Comedy and Cancer With Jesse Case: The Laughs Are Real

By on November 19th, 2015 Categories: Community Knowledge

 29-year-old comedian Jesse Case and his family connected to three years ago when his aunt was diagnosed with metastatic breast cancer. Last month, we brought you part one of this interview.

“I have no idea why I’m wearing a lei,” Jesse writes from his parents’ house in Nashville. He’s sending what photos he can find. Most pictures of Jesse performing standup are back in …

Our Friends Answer: What Do You Think of the New Breast Cancer Screening Guidelines?

By on November 12th, 2015 Categories: Research News

The American Cancer Society (ACS) made news on October 20 when they released updated breast cancer screening guidelines. The new guidelines recommend that women at average risk start regular annual screening with mammography at age 45 and move to screening every 2 years at age 55. The guidelines also say that women ages 40 to 44 should have the option to begin screening early, …

Writing & Healing Contest Winners

By on November 4th, 2015 Categories: The Breast Cancer Journey

When asked if I could help create a writing contest with winners, I thought to myself that each writing and submission would already be a winner in the important ways.

They were all a pleasure to read, offering many feelings through interesting objects. There was joy and grief and humor as well as a great deal of resiliency.

The three winners all told their story …

What My Patients Are Asking: What Do the TAILORx Trial Results Mean For Me?

By on October 30th, 2015 Categories: Research News

First results from the TAILORx trial (Trial Assigning IndividuaLized Options for Treatment) were published on Sept. 28, 2105 by the New England Journal of Medicine.

This powerful study showed that women eligible for the Oncotype DX test and who have an Oncotype DX Recurrence Score between 0 and 10 can safely skip chemotherapy.

The Oncotype DX test is a genomic test that analyzes the …

Page 1 of 3412345...102030...Last »
Back to top is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information. 120 East Lancaster Avenue, Suite 201 Ardmore, PA 19003

© 2015 - All rights reserved.